Active Ingredient History

  • Now
Otenabant (CP-945,598) is a drug which acts as a potent and highly selective CB1 antagonist. It was developed by Pfizer for the treatment of obesity, but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.   Wikipedia

  • SMILES: CCNC1(CCN(CC1)c2ncnc3c2nc(c4ccccc4Cl)n3c5ccc(Cl)cc5)C(=O)N
  • Mol. Mass: 510.43
  • ALogP: 4.22
  • ChEMBL Molecule:
More Chemistry
1-(9-(4-chlorophenyl)-8-(2-chlorophenyl)-9h-purin-6-yl)-4-ethylaminopiperidine-4-carboxylic acid amide | cp945598 | cp 945598 | cp-945598 | cp-945,598 | cp-945598-01 | otenabant | otenabant hcl


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue